Clinical Trial

ActivE³ - Everyone, Everywhere, Everyday WP 2 - Personalized Data-driven Coaching Platform for Stimulating and Promoting Active Lifestyle and Health Risk Prevention

Study acronym: Active3-WP2
Completed
View on ClinicalTrials.gov →
Summary
The objective of WP2 of the Active3 project is to develop a digital solution for promoting and monitoring physical activity in social settings (real or virtual) that implements a Preventive Medicine approach to healthy aging. Specifically, the objective of the action related to Word Package 2 is to develop a personalized, data-driven coaching platform co-designed with local healthcare services, clinicians, technologists, designers, and management engineers to stimulate and promote an active lifestyle and prevent health risks among the over-60 population in Lecco and its province. Active Healthy Aging initiatives, such as the Walking Groups coordinated by local healthcare services, are already active in the Lecco area. This personalized coaching platform aims to leverage these initiatives for prevention and treatment purposes. Its objectives are: * Creating a user-friendly technological tool for local healthcare services/clinical organizations for projects encouraging physical activity as a driver of lifestyle-based prevention; * Test this digital therapeutic practice (with a clinical study) on a cohort of 200 individuals to validate its usability, adherence and preliminary efficacy. The main questions it aims to answer are: Will a Digital Therapeutics (DTx) based on Active Lifestyle and balance nutrition promotion be adopted and used in an elderly propulation? What outcomes in health scores will Active3-WP2 platform achieve in physical, metabolic and cognitive domains? Researchers will compare the use of the proposed DTxA to a contrl gropu receiving a standard educational program. Participants will: * receive the Active3-WP2 platform (App+ Wearable) * participate in health screenings at month 0, month 6 and month 12.
Trial Details
NCT Number NCT07350915
Lead Sponsor Politecnico di Milano
Conditions Healthy
Enrollment 237 participants
Start Date 2024-09-01
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-20